Hyperion Defi (HYPD) Preferred Dividend Payments (2025 - 2026)
Hyperion Defi (HYPD) posted quarterly Preferred Dividend Payments of $4.8 million for Q1 2026, up 504.3% quarter-over-quarter from $792616.0 in Q4 2025.
Hyperion Defi (HYPD) Preferred Dividend Payments (2025 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Preferred Dividend Payments for 2 consecutive years, with $4.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Preferred Dividend Payments changed N/A year-over-year to $4.8 million; the TTM figure through Mar 2026 stood at $6.5 million (changed N/A YoY), while the FY2025 annual figure was $1.7 million, changed N/A from the prior year.
- Preferred Dividend Payments advanced to $4.8 million in Q1 2026 per HYPD's latest filing, from $792616.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $4.8 million in Q1 2026 and bottomed at $97167.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Hyperion Defi | 44.65 Mn | 35.01 Mn | 357,693.00 | 15.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.89 Mn |
| Mar 31, 2026 | 4.79 Mn |
| Dec 31, 2025 | 792,616.00 |
| Sep 30, 2025 | 795,000.00 |
| Jun 30, 2025 | 97,167.00 |